Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1184660.RAphN-vbeZx2uI0LAH87pdvFoQ3XYXYw2wYltUNVFGVOw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1184660.RAphN-vbeZx2uI0LAH87pdvFoQ3XYXYw2wYltUNVFGVOw130_assertion type Assertion NP1184660.RAphN-vbeZx2uI0LAH87pdvFoQ3XYXYw2wYltUNVFGVOw130_head.
- NP1184660.RAphN-vbeZx2uI0LAH87pdvFoQ3XYXYw2wYltUNVFGVOw130_assertion description "[The rate of KRAS mutations in plasma was low (5/170 = 3%) compared with the rate observed in the matched adenocarcinoma and HGIN tissues (45%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1184660.RAphN-vbeZx2uI0LAH87pdvFoQ3XYXYw2wYltUNVFGVOw130_provenance.
- NP1184660.RAphN-vbeZx2uI0LAH87pdvFoQ3XYXYw2wYltUNVFGVOw130_assertion evidence source_evidence_literature NP1184660.RAphN-vbeZx2uI0LAH87pdvFoQ3XYXYw2wYltUNVFGVOw130_provenance.
- NP1184660.RAphN-vbeZx2uI0LAH87pdvFoQ3XYXYw2wYltUNVFGVOw130_assertion SIO_000772 24852853 NP1184660.RAphN-vbeZx2uI0LAH87pdvFoQ3XYXYw2wYltUNVFGVOw130_provenance.
- NP1184660.RAphN-vbeZx2uI0LAH87pdvFoQ3XYXYw2wYltUNVFGVOw130_assertion wasDerivedFrom befree-2016 NP1184660.RAphN-vbeZx2uI0LAH87pdvFoQ3XYXYw2wYltUNVFGVOw130_provenance.
- NP1184660.RAphN-vbeZx2uI0LAH87pdvFoQ3XYXYw2wYltUNVFGVOw130_assertion wasGeneratedBy ECO_0000203 NP1184660.RAphN-vbeZx2uI0LAH87pdvFoQ3XYXYw2wYltUNVFGVOw130_provenance.